<DOC>
	<DOCNO>NCT03101293</DOCNO>
	<brief_summary>The purpose study determine pharmacokinetic ( PK ) single oral dose TAK-831 400 milligram ( mg ) fast state estimate effect food PK single oral dose TAK-831 400 mg administer tablet formulation healthy participant .</brief_summary>
	<brief_title>A Study Evaluate Effect Food Pharmacokinetics TAK-831 Tablet Formulation</brief_title>
	<detailed_description>The drug test study call TAK-831 . TAK-831 test healthy participant order determine effect food PK single oral dose TAK-831 tablet formulation . The study enroll approximately 16 participant . Participants randomly equally assign ( chance , like flip coin ) 1 2 treatment sequence follow : - TAK-831 400 mg Fasted + TAK-831 400 mg Fed - TAK-831 400 mg Fed + TAK-831 400 mg Fasted All participant ask take single oral dose TAK-831 tablet time Day 1 Intervention Period . This single center trial conduct United States . The overall time participate study 23 day . Participants visit clinic Day -1 remain confined Day 3 Intervention Period 1 2 . A washout period minimum 7 day maintain dos Intervention Period . Participants make 3 visit clinic Days 4 , 6 8 Intervention Period contact telephone 14 day last dose study drug ( Day 23 ) follow-up assessment .</detailed_description>
	<criteria>1 . Weighs great equal ( &gt; = ) 45 kilogram ( kg ) body mass index ( BMI ) 18.0 30.0 kilogram per square meter ( kg/m^2 ) , inclusive Screening . 1 . Has receive TAK831 previous clinical study . 2 . Has poor peripheral venous access . 3 . Has donate lose 450 milliliter ( mL ) blood volume ( include plasmapheresis ) , transfusion blood product within 45 day prior first dose study drug . 4 . Has dietary restriction preference may interfere conduct study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Drug therapy</keyword>
</DOC>